trans-3-Methoxycyclobutan-1-ol

Catalog No.: 
ACPRDT092
CAS No.: 
1819983-03-3
Molecular Formula: 
C5H10O2
Molecular Weight: 
102.13
trans-3-Methoxycyclobutan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$104.00In stockInquiry
250mg95%$207.00In stockInquiry
1g95%$516.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametrans-3-Methoxycyclobutan-1-ol
IUPAC Name(1r,3r)-3-methoxycyclobutan-1-ol
MDL No.MFCD22397418
Molecular FormulaC5H10O2
Molecular Weight102.13
SMILESO[C@H]1C[C@H](OC)C1
InChI KeyOSYROIVZPXZWOK-URHBZAFASA-N
Synonym1432680-25-5 | AS-84015 | SCHEMBL17196020 | trans-3-Methoxycyclobutanol | rel-(1R,3R)-3-Methoxycyclobutan-1-ol (trans) | trans-3-Methoxycyclobutan-1-ol | trans-?3-?Methoxycyclobutanol | EN300-321304 | 3-Methoxycyclobutanol | SCHEMBL17338791 | MFCD22397418
CAS No.1819983-03-3
PubChem CID57579990

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPRDT092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPRDT092 route product structure diagram
    ACPRDT0921819983-03-3In Stock
Inquiry

2. ACPRDT092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPRDT092 route product structure diagram
    ACPRDT0921819983-03-3In Stock
Inquiry

3. ACPRDT092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPRDT092 route product structure diagram
    ACPRDT0921819983-03-3In Stock
Inquiry

Comments (0)